Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomised, Controlled, Open Study. Phase II Treatment Equivalent.

NCT00429013 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT00429013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00429013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomised, Controlled, Open Study. Phase II Treatment Equivalent.
Lead sponsor
University Hospital, Grenoble
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2006
Completion date
March 31, 2009
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paraplegia